Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.31 | 49.50 |
| PEG Ratio (TTM) | -0.11 | 4.50 |
| P/S Ratio (TTM) | 0.54 | 13.78 |
| P/B Ratio (TTM) | 0.25 | 7.34 |
| P/FCF Ratio (TTM) | -2.09 | 229.30 |
| Price to 5YR AVG Earnings Ratio | 1.43 | 105.54 |
| Price to 5YR AVG FCF Ratio | -4.26 | 97.57 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -9.97% | 6.72% |
| ROE (TTM) | -17.11% | 11.28% |
| Net Profit Margin (TTM) | -41.11% | -0.16% |
| ROIC 5YR AVG | 29.38% | 11.39% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -792.45% | 452.74% | 201.46% |
| Revenue | 10.60% | 83.86% | 29.58% |
| Net Income | -631.39% | 378.61% | 161.37% |
| Cash Flow | -107.01% | 373.94% | 197.89% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 8.57 | 3.26 |
| Quick Ratio (TTM) | 5.92 | 2.48 |
| D/E Ratio (TTM) | 0.02 | 0.51 |
| Interest Coverage (TTM) | -127.36 | 39.67 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.92 | 27.26 |
| LTL to 5YR AVG FCF | -0.25 | 4.14 |
| Shares Outstanding Growth 5YR AVG | -1.64% | 0.91% |